Studies relating to the antihypertensive and antidysrhythmic action of indoramin.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001341:Autonomic Nervous System / Q000187:drug effects; D001549:Benzamides / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002346:Carotid Sinus / Q000502:physiology; D003714:Denervation; D004285:Dogs; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology*; D007668:Kidney / Q000502:physiology; D009392:Nephrectomy; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014630:Vagus Nerve / Q000502:physiology
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001549:Benzamides; D007211:Indoles; D010627:Phenethylamines; D010880:Piperidines; D000804:Angiotensin II; D009638:Norepinephrine; D004837:Epinephrine